Comparison between two treatment protocols with recombinant Human Erythropoietin (rHuEpo) in the treatment of late anemia in neonates with Rh-Isoimmunization
Objectve. The Rh-hemolytic disease can lead to a late anemia by hemolytic and hyporigenerative mechanism. We compared the effectiveness of rHuEPO in two care protocols that differ for doses of rHuEPO administrated and for timing of administration. Methods. A cohort of 14 neonates was investigated. T...
Saved in:
Main Authors: | A.A. Zuppa (Author), G. Alighieri (Author), A. Fracchiolla (Author), P. Catenazzi (Author), A. D'Antuono (Author), R. Riccardi (Author), M. Cavani (Author), C. Romagnoli (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2012-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
by: Farooqahmed S. Kittur, et al.
Published: (2023) -
A comparative pharmacokinetic and pharmacodynamic study of two novel Cuban PEGylated rHuEPO versus MIRCERA® and ior®EPOCIM
by: Gledys Reynaldo, et al.
Published: (2018) -
Toward a bioethical issue: induced multiple pregnancies and neonatal outcomes
by: Scorrano Antonio, et al.
Published: (2010) -
Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor
by: Ilaria Cervellini, et al.
Published: (2013) -
Erythropoietin Receptor (EpoR) Agonism Is Used to Treat a Wide Range of Disease
by: Fabian Sanchis-Gomar, et al.
Published: (2013)